Transoral robotic surgery for oropharyngeal carcinoma: Surgical margins and oncologic outcomes
Head & Neck Jan 18, 2018
Moore EJ, et al. - The objective of this research was to evaluate the oncologic outcomes after transoral robotic surgery (TORS) ± adjuvant therapy for oropharyngeal squamous cell carcinoma (SCC). It was determined that the necessity of taking ≥2 margins to achieve resection pointed towards an increased risk of locoregional recurrence and death due to disease in oropharyngeal SCC.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries